see also National Cancer Data Base;

Surveillance, Epidemiology, and End Results program

Cancer Surveillance Research Program, 185

Centers for Disease Control and Prevention, 11, 18-19, 49, 154, 180 , 185, 197-199, 224

Cervical cancer, 11, 14, 22, 42, 51, 171, 187, 189, 190, 192, 193

Pap smears, 22, 51, 54-55, 56, 57, 190

research funding, 185, 187

Cervical Cancer Early Detection Program, 11

Chemotherapy, 3, 4, 22, 23, 30, 31, 49, 58, 60, 62, 82, 83, 88, 217

breast cancer, 60, 82, 94-95, 96, 98-99, 109, 129, 167, 171, 173, 174

clinical practice guidelines, 166, 169-170, 173, 174

insurance coverage, 50, 59

international perspectives, 171-172

lung cancer, 166-167, 190

prostate cancer, 107

side-effects, 24

specialty care and, 128, 129, 130, 131

standards, 164

see also Drugs

Children, 19, 49, 188, 195-196, 206

incidence, 20

treatment, 34, 62

Clinical practice guidelines, 4-5, 7-8, 15, 18, 23, 34, 43, 62, 64 -65, 99, 119, 133, 144, 148, 154-155, 164-174, 175, 195, 212, 220

American Society of Clinical Oncology, 26, 166-167

breast cancer, 99, 165, 166, 167, 169, 171, 173, 174

chemotherapy, 166, 169-170, 173, 174

colorectal cancer, 166, 169, 171, 172, 173, 174

defined, 164-165

lung cancer, 166-167, 169, 172

managed care, 172

ovarian cancer, 171, 172, 174

patient education, 165, 168, 173

proprietary, 166

prostate cancer, 165, 170-171, 172

surgery, 99, 133, 166, 167, 170-171, 172

Clinical trials, 4, 8, 23, 62-63, 117, 129, 146, 181, 182, 187, 191 , 194-195, 200, 213, 217, 220, 221

age factors, 62, 63

breast cancer, 94, 132

evidence criteria, 82, 194

funding, 8, 43, 221

insurance coverage, 43, 63

international perspectives, 34

managed care, 37, 41, 63

minority groups, 34, 62-63

NCI, 34, 62, 99

postoperative survival, 83

private sector, 8, 213

prostate cancer, 103

publication bias, 118, 138

standards, 162

women, 62-63, 94, 132

Cochrane Collaboration, 207, 208-209

Colorectal cancer, 88, 156

adjuvant therapy, 173

chemotherapy, 83, 173

clinical practice guidelines, 166, 169, 171, 172, 173, 174

cost of, 36, 199

elderly persons, 51, 153

incidence, 20

insurance, 42, 136

minorities, 47

screening, 22, 42, 51, 54, 57, 58, 193, 198, 199, 203, 205

treatment, 27, 28, 30, 31, 61, 82, 83, 88, 132-133, 153, 156, 173, 203, 204

Community Clinical Oncology Program, 34, 99

Community Hospital Oncology Program, 168-169

Complementary treatments, 24, 204

Continuous quality improvement programs, 163-164

Cooperative Group Program, 34

Coordination of care, 7, 26, 30, 41, 46, 214, 215, 220

disease management specialists, 40-41, 133

federal, 2, 19, 41, 145, 175

Costs, 20, 35-36, 182, 194, 206

age factors, 36

breast cancer, 36

clinical practice guidelines, 172-173

colorectal cancer, 36, 199

disease management specialists, 40-41, 133

individual patient, 10, 20, 35, 47, 48, 50, 64

insurance premiums, 47, 48, 50, 52

national costs of cancer, general, 20, 35-36, 41

out-of-pocket, 50, 52, 57, 59, 64, 66

screening, 50, 52, 57, 186, 189, 190

treatment, general, 35, 186, 189, 190



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement